Medicine and Dentistry
Diseases
100%
Neoplasm
88%
Mouth Squamous Cell Carcinoma
87%
Biological Marker
50%
Malignant Neoplasm
50%
Oropharynx Squamous Cell Carcinoma
46%
Ovarian Cancer
43%
Methylation
39%
Vasculotropin Antibody
36%
Allele
35%
DNA Polymorphism
35%
Vasculotropin
35%
Head and Neck Squamous Cell Carcinoma
35%
Antiangiogenic Therapy
35%
Krukenberg Tumor
35%
Multivariate Analysis
33%
Lymph Node Metastasis
32%
Radiation Therapy
30%
Oral Cavity
28%
Tumor Progression
27%
Immunohistochemistry
24%
Cell Death
23%
Oropharynx
21%
Squamous Cell Carcinoma
21%
Promoter Region
21%
In Vitro
21%
Bevacizumab
21%
Antibody Therapy
20%
Low Drug Dose
18%
Glutaminase
17%
Breast Cancer
17%
Fibroblast
17%
Nuclear Export
17%
Tumor Angiogenesis
17%
Glutamine
17%
Prolactin Receptor
17%
Hazard Ratio
17%
Lymphoid Cell
17%
Uterine Cancer
17%
Keratin 17
17%
Plasminogen Activator Inhibitor-1
17%
Tumor Necrosis Factor
17%
Genomic Instability
17%
Death Associated Protein Kinase
17%
Breast Cancer Cell Line
17%
Genetic Variability
17%
Glyphosate
17%
Protein P53
17%
Keratin 19
17%
Exome Sequencing
17%
Keyphrases
Oral Tongue Squamous Cell Carcinoma (OTSCC)
73%
Prognostic Marker
55%
Esprito Santo
52%
Ovarian Cancer
43%
High-grade Serous Ovarian Cancer (HGSOC)
42%
Pomeranian
37%
Tumor
36%
Adaptive Resistance
35%
P130Cas
35%
Anti-angiogenesis
35%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
35%
Oral and Oropharyngeal Squamous Cell Carcinoma
35%
Antiangiogenesis Therapy
35%
Runt-related Transcription Factor 3 (RUNX3)
26%
Expression Profile
24%
Promoter Methylation
24%
Hypoxia-inducible factor-1α (HIF-1α)
23%
Ovarian Cancer Cells
22%
Chemotherapy
21%
Radiotherapy Response
21%
Tumor Growth
21%
Oropharynx
21%
Radiotherapy
20%
Vascular Endothelial Growth Factor
20%
Brazil
20%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
19%
Tumoral
19%
Antitumor Effect
19%
Methylation
18%
HPV Negative
17%
Fibroblasts
17%
Investigation Process
17%
Blotting
17%
Inflammatory Cells
17%
Acquired Resistance
17%
Metabolic Vulnerability
17%
Cell Line Models
17%
Group Position
17%
Mouse Model
17%
Anti-VEGF Antibody
17%
Poor Response
17%
Pathway Activation
17%
ErbB3
17%
Tumor Angiogenesis
17%
Rational Combinations
17%
Antibody Therapy
17%
Olaparib
17%
Research Integrity
17%
Jumonji Domain
17%
Mild Intellectual Disability
17%
Biochemistry, Genetics and Molecular Biology
Allele
55%
Methylation
39%
Methylenetetrahydrofolate Reductase
35%
Vascular Endothelial Growth Factor
35%
Gene Polymorphism
35%
Cancer Cell
30%
Multivariate Analysis
30%
Population
27%
Genetic Divergence
26%
RUNX3
26%
Promoter Region
23%
Oropharynx
23%
Genotyping
23%
Tumor Progression
22%
Gene Expression
21%
Restriction Fragment Length Polymorphism
21%
Metabolic Pathway
21%
Genetics
20%
Polymerase Chain Reaction
19%
DNA Repair
19%
Fibroblast
17%
Loss of Heterozygosity
17%
Keratin 17
17%
Membrane Protein
17%
Transmembrane Protein
17%
Microsatellite Instability
17%
Lysin
17%
Steroid Metabolism
17%
Precursor
17%
Tumor Necrosis Factor
17%
Tumor Necrosis Factor Alpha
17%
Transcriptomics
17%
Low Drug Dose
17%
ERBB3
17%
Metabolite
17%
Lymphotoxin
17%
Cystic Fibrosis
17%
Hypoxanthine-Guanine Phosphoribosyltransferase
17%
Lymphotoxin Alpha
17%
Paxillin
17%
Intellectual Disability
17%
Nuclear Export
17%
Amino Methyl Phosphonic Acid
17%
Cell Cycle
17%
Keratin
17%
Small Extracellular Vesicles
17%
P53
17%
Angiogenesis
17%
Vascular Endothelial Growth Factor A
17%
Basic Fibroblast Growth Factor
17%
